Cambridge Investment Research Advisors’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$332K Buy
17,281
+2,758
+19% +$54.3K ﹤0.01% 3188
2025
Q4
$275K Sell
14,523
-1,369
-9% -$25.4K ﹤0.01% 3287
2025
Q3
$296K Sell
15,892
-1,666
-9% -$31.1K ﹤0.01% 3120
2025
Q2
$324K Sell
17,558
-1,363
-7% -$24.2K ﹤0.01% 2915
2025
Q1
$331K Buy
18,921
+853
+5% +$14.4K ﹤0.01% 2771
2024
Q4
$313K Buy
18,068
+41
+0.2% +$749 ﹤0.01% 2801
2024
Q3
$335K Sell
18,027
-9,835
-35% -$166K ﹤0.01% 2749
2024
Q2
$429K Buy
27,862
+2,560
+10% +$36.6K ﹤0.01% 2424
2024
Q1
$374K Buy
25,302
+4,088
+19% +$56.6K ﹤0.01% 2529
2023
Q4
$303K Sell
21,214
-9,908
-32% -$141K ﹤0.01% 2589
2023
Q3
$434K Sell
31,122
-1,694
-5% -$21.7K ﹤0.01% 2204
2023
Q2
$386K Sell
32,816
-4,350
-12% -$49.5K ﹤0.01% 2333
2023
Q1
$427K Buy
37,166
+11,538
+45% +$143K ﹤0.01% 2203
2022
Q4
$319K Sell
25,628
-1,181
-4% -$15.1K ﹤0.01% 2384
2022
Q3
$352K Sell
26,809
-1,138
-4% -$16.8K ﹤0.01% 2239
2022
Q2
$390K Sell
27,947
-3,569
-11% -$47.7K ﹤0.01% 2151
2022
Q1
$469K Sell
31,516
-1,895
-6% -$25.9K ﹤0.01% 2159
2021
Q4
$452K Buy
33,411
+5,404
+19% +$76.5K ﹤0.01% 2188
2021
Q3
$412K Sell
28,007
-5,498
-16% -$92.9K ﹤0.01% 2198
2021
Q2
$610K Sell
33,505
-1,246
-4% -$22.2K ﹤0.01% 1900
2021
Q1
$603K Sell
34,751
-6,994
-17% -$123K ﹤0.01% 1766
2020
Q4
$725K Sell
41,745
-2,593
-6% -$41.4K ﹤0.01% 1518
2020
Q3
$611K Buy
44,338
+2,605
+6% +$38.3K ﹤0.01% 1481
2020
Q2
$602K Buy
41,733
+3,200
+8% +$42.1K ﹤0.01% 1453
2020
Q1
$421K Buy
38,533
+1,152
+3% +$21.2K ﹤0.01% 1472
2019
Q4
$798K Buy
37,381
+699
+2% +$15.7K 0.01% 1288
2019
Q3
$842K Buy
36,682
+2,890
+9% +$61.6K 0.01% 1171
2019
Q2
$665K Sell
33,792
-1,817
-5% -$35.4K 0.01% 1261
2019
Q1
$693K Buy
35,609
+881
+3% +$16.7K 0.01% 1268
2018
Q4
$572K Sell
34,728
-6,710
-16% -$135K 0.01% 1241
2018
Q3
$958K Buy
41,438
+3,771
+10% +$85.4K 0.01% 1046
2018
Q2
$819K Buy
37,667
+6,191
+20% +$121K 0.01% 1093
2018
Q1
$556K Buy
31,476
+1,201
+4% +$21.2K 0.01% 1289
2017
Q4
$568K Buy
30,275
+7,432
+33% +$148K 0.01% 1254
2017
Q3
$501K Buy
+22,843
New +$516K 0.01% 1257

Other funds holding SBRA